Viridian Therapeutics, Inc. (VRDN)
30.87
+0.39
(+1.28%)
USD |
NASDAQ |
Nov 13, 16:00
30.86
-0.01
(-0.03%)
After-Hours: 19:59
Viridian Therapeutics Profit Margin (Quarterly) : -393.0% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -393.0% |
| June 30, 2026 | -44.76K% |
| March 31, 2026 | -74.40K% |
| December 31, 2025 | -77.26K% |
| September 30, 2025 | -49.03% |
| June 30, 2025 | -134.3K% |
| March 31, 2025 | -120.7K% |
| December 31, 2024 | -89.79K% |
| September 30, 2024 | -89.17K% |
| June 30, 2024 | -90.27K% |
| March 31, 2024 | -67.42K% |
| December 31, 2023 | -92.86K% |
| September 30, 2023 | -66.19K% |
| June 30, 2023 | -76.48K% |
| March 31, 2023 | -69.54K% |
| December 31, 2022 | -43.60K% |
| September 30, 2022 | -2.42K% |
| June 30, 2022 | -11.52K% |
| March 31, 2022 | -11.89K% |
| December 31, 2021 | -13.53K% |
| September 30, 2021 | -6.75K% |
| June 30, 2021 | -1.65K% |
| March 31, 2021 | -1.27K% |
| December 31, 2020 | -168.0K% |
| September 30, 2020 |
| Date | Value |
|---|---|
| June 30, 2020 | -3.83K% |
| March 31, 2020 | -971.5% |
| December 31, 2019 | -1.15K% |
| September 30, 2019 | -1.62K% |
| June 30, 2019 | -353.9% |
| March 31, 2019 | -3.13K% |
| December 31, 2018 | -2.17K% |
| September 30, 2018 | -954.6% |
| June 30, 2018 | -399.4% |
| March 31, 2018 | -97.43% |
| December 31, 2017 | -535.7% |
| September 30, 2017 | -357.7% |
| June 30, 2017 | -1.02K% |
| March 31, 2017 | -1.51K% |
| December 31, 2016 | -1.18K% |
| September 30, 2016 | -445.1% |
| June 30, 2016 | -286.8% |
| March 31, 2016 | -337.2% |
| December 31, 2015 | -452.2% |
| September 30, 2015 | -629.1% |
| June 30, 2015 | -349.0% |
| March 31, 2015 | -408.4% |
| December 31, 2014 | -345.0% |
| September 30, 2014 | -125.8% |
| June 30, 2014 | -258.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Travere Therapeutics, Inc. | -27.18% |
| Arrowhead Pharmaceuticals, Inc. | -1.13K% |
| Vertex Pharmaceuticals, Inc. | 19.01% |
| TG Therapeutics, Inc. | 21.34% |
| ACADIA Pharmaceuticals, Inc. | 15.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.11% |
| Return on Assets | -49.55% |
| Return on Invested Capital | -58.56% |
| Gross Profit Margin (Quarterly) | 92.74% |
| Operating Margin (Quarterly) | -401.8% |
| Return on Net Operating Assets | -1.54K% |